Order results by:
Issue | Title | |
Vol 4, No 4 (2008) | NEWS FROM EUROPEAN CONGRESS OF CARDIOLOGY (MUNICH, 2008): SUCCESS AND DISAPPOINTMENT | Abstract similar documents |
S. Y. Martsevich | ||
Vol 17, No 4 (2021) | Changes in anticoagulant prescription in a general hospital in 2008-2018 | Abstract similar documents |
E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev | ||
"... to retrospective retrieval from electronic health records, total 17,129 patients received anticoagulants from 2008 ..." | ||
Vol 4, No 5 (2008) | NEWS FROM CONGRESS OF AMERICAN HEART ASSOCIATION (NEW ORLEANS, NOVEMBER 2008): WHICH CONCLUSIONS WILL BE DONE FOR PRACTICAL MEDICINE | Abstract similar documents |
S. Y. Martsevich | ||
Vol 5, No 1 (2009) | NEW DEFINITIONS OF MYOCARDIAL INFARCTIONS (COMMENTS ON “UNIVERSAL DEFINITIONS OF MYOCARDIAL INFARCTION” PUBLISHED IN №5, 2008) | Abstract similar documents |
A. V. Shpector, E. Yu. Vasilyeva | ||
"... New definitions of myocardial infarctions (comments on “Universal definitions of myocardial ..." | ||
Vol 4, No 3 (2008) | NEWS FROM THE ANNUAL CONGRESS ON ARTERIAL HYPERTENSION (BERLIN, JUNE 2008): CHANGES IN THE TREATMENT STRATEGY ARE PLANNING | Abstract similar documents |
S. Y. Martsevich | ||
Vol 4, No 5 (2008) | CRESTOR SHOWN SIGNIFICANT REDUCTION OF CARDIOVASCULAR RISK IN A LARGE CLINICAL TRIAL | Abstract similar documents |
статья Редакционная | ||
"... ПРЕСС-РЕЛИЗ КОМПАНИИ АСТРАЗЕНЕКА. Результатыисследования JUPITER были представлены 9 ноября 2008 ..." | ||
Vol 5, No 3 (2009) | ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE 2008 | Abstract similar documents |
Kenneth Dickstein, Alain Cohen-Solal, Gerasimos Filippatos, John J.V. McMurray, Piotr Ponikowski, Philip Alexander Poole-Wilson, Anna Stromberg, Dirk J. van Veldhuisen, Dan Atar, Arno W. Hoes, Andre Keren, Alexandre Mebazaa, Markku Nieminen, Silvia Giuliana Priori, Karl Swedberg | ||
"... ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. ..." | ||
Vol 5, No 4 (2009) | ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE 2008 (ENDING) | Abstract similar documents |
Kenneth Dickstein, Alain Cohen-Solal, Gerasimos Filippatos, John J.V. McMurray, Piotr Ponikowski, Philip Alexander Poole-Wilson, Anna Stromberg, Dirk J. van Veldhuisen, Dan Atar, Arno W. Hoes, Andre Keren, Alexandre Mebazaa, Markku Nieminen, Silvia Giuliana Priori, Karl Swedberg, M. O. Evseev | ||
"... ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (ending). ..." | ||
Vol 4, No 2 (2008) | ACUTE CORONARY SYNDROME IN PATIENTS WITH DIABETES MELLITUS: ON THE WAY TO MUNICH-2008 | Abstract similar documents |
I. I. Dedov, A. A. Alexanrov | ||
Vol 3, No 5 (2007) | RUSSIAN NATIONAL CONGRESS OF CARDIOLOGISTS, 7-9 OCTOBER, MOSCOW | Abstract similar documents |
"... Российский национальный конгресс кардиологов, 7-9 октября 2008, Москва. ..." | ||
Vol 6, No 1 (2010) | UNIFORM REQUIREMENTS FOR MANUSCRIPT SUBMITTED TO BIOMEDICAL JOURNALS: WRITING AND EDITING FOR BIOMEDICAL PUBLICATION (2008) | Abstract similar documents |
T. A. Kazakovceva | ||
Vol 6, No 2 (2010) | UNIFORM REQUIREMENTS FOR MANUSCRIPT SUBMITTED TO BIOMEDICAL JOURNALS: WRITING AND EDITING FOR BIOMEDICAL PUBLICATION (2008) | Abstract similar documents |
T. A. Kazakovceva | ||
"... for Biomedical Publication (2008). ..." | ||
Vol 5, No 6 (2009) | EUROPEAN GUIDELINES ON MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH PERSISTENT ST-SEGMENT ELEVATION 2008. WHAT CHANGED? (COMMENTS TO UPDATED) | Abstract similar documents |
R. M. Linchak, V. S. Popov | ||
"... with persistent ST-segment elevation 2008. What changed? (comments to updated). ..." | ||
Vol 11, No 1 (2015) | ON THE SELECTION OF DRUGS DOSAGE REGIMEN | Abstract similar documents |
E. N. Bochanova | ||
Vol 11, No 6 (2015) | Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events | Abstract similar documents |
O. V. Shatalova | ||
Vol 17, No 6 (2021) | Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 1: Predictors of the Development of an Unfavorable Prognosis | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva | ||
"... (LVEF) on the prognosis of patients with a verified diagnosis of a new coronavirus infection SARS-CoV-2 ..." | ||
Vol 12, No 2 (2016) | THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE | Abstract similar documents |
S. V. Moiseev | ||
"... New oral anticoagulants that inhibit factor Xa (rivaroxaban, apixaban, edoksaban) or thrombin ..." | ||
Vol 12, No 3 (2016) | THE PHARMACOKINETICS OF APIXABAN IN PATIENTS WITH CARDIOEMBOLIC STROKE IN ACUTE PHASE | Abstract PDF (Eng) similar documents |
A. V. Kryukov, D. A. Sychev, D. A. Andreev, A. V. Ryabova, N. P. Denisenko, M. A. Loskutnikov, O. I. Vinogradov, M. A. Domashenko | ||
"... with cardioembolic stroke in acute phase. It could be the basis for the development of new personalized approaches ..." | ||
Vol 12, No 3 (2016) | THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT | Abstract PDF (Eng) similar documents |
S. R. Gilyarevskiy | ||
"... , as well as the choice of anticoagulants, including new oral anticoagulants (NOAC). EINSTEIN-PE is the only ..." | ||
Vol 13, No 1 (2017) | DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT | Abstract similar documents |
D. А. Napalkov, A. A. Sokolova, V. V. Fomin | ||
"... . The analysis of various RCP data bases published over the past 2 years shows that, among all new oral ..." | ||
Vol 13, No 3 (2017) | PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION | Abstract similar documents |
A. V. Kryukov, D. A. Sychev, O. V. Tereshchenko | ||
"... parameters of new oral anticoagulants. The review presents data from studies investigating the effect of gene ..." | ||
Vol 15, No 6 (2019) | Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study) | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, N. A. Komkova | ||
"... Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated ..." | ||
Vol 9, No 5 (2013) | PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko | ||
"... Disadvantages of vitamin K antagonist warfarin and the benefits of new anticoagulants, including ..." | ||
Vol 10, No 6 (2014) | THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER | Abstract similar documents |
S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina | ||
"... Aim. To study in the PROFILE register the rate of new oral anticoagulants (NOAC) taking ..." | ||
Vol 10, No 6 (2014) | THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY | Abstract similar documents |
A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev | ||
"... problems. New oral anticoagulants (NOAC) are promising drugs for use in oncology practice; however ..." | ||
Vol 17, No 2 (2021) | The Importance of Antihypertensive and Lipid-Lowering Therapy in the Treatment of Patients with a New Coronavirus Infection COVID-19 | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
"... At the end of 2020, a new term “post-COVID-19 syndrome” appeared in the medical community ..." | ||
Vol 12, No 6 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract PDF (Eng) similar documents |
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
"... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..." | ||
Vol 12, No 1 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract similar documents |
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
"... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..." | ||
Vol 3, No 1 (2007) | HIGHER CERTIFYING COMMISSION NEWS | Abstract similar documents |
"... Higher Certifying Commission News. ..." | ||
Vol 3, No 2 (2007) | HIGHER CERTIFYING COMMISSION NEWS | Abstract similar documents |
"... Higher Certifying Commission News. ..." | ||
Vol 8, No 2 (2012) | CARDIOPULMONARY RESUSCITATION: A NEW PERSPECTIVE | Abstract similar documents |
V. A. Sulimov, Yu. V. Gavrilov, E. O. Okisheva | ||
Vol 3, No 5 (2007) | HIGHER CERTIFYING COMMISSION NEWS | Abstract similar documents |
"... Higher Certifying Commission News. ..." | ||
Vol 14, No 4 (2018) | Hepatotoxicity of New Oral Anticoagulants | Abstract similar documents |
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin | ||
"... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..." | ||
Vol 2, No 4 (2006) | HIGHER CERTIFYING COMMISSION NEWS | similar documents |
Vol 7, No 1 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS | Abstract similar documents |
M. Yu. Gilyarov, V. A. Sulimov | ||
"... New data and perspectives of antithrombotic therapy are highlighted in patients with atrial ..." | ||
Vol 1, No 3 (2005) | CONGRESS OF AMERICAN HEART ASSOCIATION 2005: NEW RESULTS, NEW PROBLEMS | Abstract similar documents |
S. Yu. Martsevich | ||
"... Congress of American Heart Association 2005: new results, new problems. ..." | ||
Vol 5, No 2 (2009) | NEW PATHOGENIC MECHANISMS OF THE CHRONIC PERICARDITIS | Abstract similar documents |
V. V. Kochmasheva, E. D. Rozhdestvenskaya, E. S. Belikov, M. A. Dergunova, M. V. Arhipov | ||
"... progression and new pathogenesis mechanisms is discussed. ..." | ||
Vol 7, No 1 (2011) | NEW ANTIPLATELET DRUGS (PART 1) | Abstract similar documents |
A. B. Sumarokov | ||
"... agents is still very limited. Pharmacology of antiplatelet drugs is growing rapidly. Some of new ..." | ||
Vol 7, No 5 (2011) | NEW ANTIPLATELET DRUGS. PART 2 | Abstract similar documents |
A. B. Sumarokov | ||
"... limited. Pharmacology of antiplatelet drug has been developing rapidly. New antiplatelet drugs ..." | ||
Vol 10, No 4 (2014) | NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY | Abstract similar documents |
D. A. Napalkov, A. A. Sokolova | ||
"... Comparative analysis of oral anticoagulants (vitamin K antagonists and new drugs, including ..." | ||
Vol 10, No 4 (2014) | NEW AGE OF POSTGRADUATE MEDICAL EDUCATION | Abstract similar documents |
"... New age of postgraduate medical education. ..." | ||
Vol 3, No 5 (2007) | NEWS OF CONGRESS OF AMERICAN HEART ASSOCIATION | Abstract similar documents |
S. Yu. Martsevich | ||
"... News of Congress of American heart association. ..." | ||
Vol 14, No 3 (2018) | CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin | ||
"... of the endothelium, and appearance of new cases of atrial fibrillation (AF) in patients with arterial hypertension ..." | ||
Vol 18, No 5 (2022) | Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 | Abstract similar documents |
A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina | ||
"... myocardial infarction (MI) – 2.5% vs 0.5% (p=0.048). The proportion of new cases of CVD in the groups ..." | ||
Vol 12, No 4 (2016) | The use of oral anticoagulants in patients with atrial fibrillation: cohort study data | Abstract similar documents |
O. V. Gaisenok, A. S. Leonov | ||
"... . Material and methods. Patients (n=58) with AF were included into the study. The rate of OAC, including new ..." | ||
Vol 12, No 5 (2016) | Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms | Abstract PDF (Eng) similar documents |
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev | ||
"... .7%; Kolmogorov-Smirnov; p<0.05). Patients receiving new oral anticoagulants (NOAC) have better compliance ..." | ||
Vol 11, No 2 (2015) | PRACTICAL ASPECTS OF APIXABAN USE IN CLINICAL PRACTICE: VIEW POINT OF CLINICAL PHARMACOLOGIST | Abstract similar documents |
D. A. Sychev, I. I. Sinitsina, G. Yu. Zakharova, M. I. Savel'eva, A. V. Ryabova, A. V. Kryukov, A. Yu. Yurovskii | ||
"... Apixaban is a "new" oral anticoagulant, direct Xa factor inhibitor with a good evidence base ..." | ||
Vol 16, No 1 (2020) | Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients | Abstract similar documents |
A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin | ||
Vol 16, No 1 (2020) | The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation | Abstract similar documents |
A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva | ||
"... Aim. To study the efficacy, safety, and adherence to therapy with new oral anticoagulants ..." | ||
Vol 9, No 5 (2013) | APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA | Abstract similar documents |
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev | ||
"... response to oral anticoagulants is considered. Possible tactics of warfarin dosing and new oral ..." | ||
Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
Vol 15, No 1 (2019) | Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City | Abstract similar documents |
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich | ||
Vol 20, No 2 (2024) | The relationship of arterial hypertension, elevated low-density lipoprotein cholesterol and their combination with the occurrence of new cases of cardiovascular diseases in men and women of working age | Abstract similar documents |
S. A. Shalnova, E. B. Yarovaya, V. A. Metelskaya, E. M. Filichkina, A. V. Kapustina, V. A. Kutsenko, Yu. A. Balanova, A. E. Imaeva, G. A. Muromtseva, S. E. Evstifeeva, S. A. Maksimov, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, Yu. I. Grinshtein, R. A. Libis, O. P Rotar, I. A. Trubacheva, A. Yu. Efanov, S. S. Yakushin, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, A. O. Konradi, S. A. Boytsov, E. V Shlyakhto, O. M. Drapkina | ||
"... mmol/l). Prospective monitoring of new cases was carried out in the initial sample without patients ..." | ||
Vol 12, No 2 (2016) | THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE | Abstract similar documents |
E. S. Mazur, R. M. Rabinovich, V. V. Mazur, N. S. Kuznetsova, E. A. Kudryashova, S. V. Veselov | ||
Vol 12, No 4 (2016) | Fighting with obesity: the "gold standard" and new horizons | Abstract similar documents |
O. M. Drapkina, Yu. V. Dubolazova, S. A. Boytsov | ||
Vol 7, No 1 (2011) | NEW INSTRUCTIONS FOR AUTHORS OF JOURNAL OF RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | similar documents |
A. S. Lishuta | ||
Vol 5, No 2 (2009) | NEWS OF THE LAST CARDIOLOGY CONGRESSES: THERE IS WHAT TO THINK OVER | Abstract similar documents |
S. Y. Martsevich | ||
"... News of the last cardiology congresses: there is what to think over. ..." | ||
Vol 7, No 2 (2011) | CONTEMPORARY SIGHT AT AMLODIPINE AND NEW DRUGS OF S-AMLODIPINE | Abstract similar documents |
M. V. Leonova | ||
Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
Vol 2, No 1 (2006) | DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT | Abstract similar documents |
O. V. Andropova, V. N. Anokhin | ||
Vol 11, No 3 (2015) | THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION | Abstract similar documents |
V. I. Podzolkov, A. I. Tarzimanova | ||
Vol 9, No 4 (2013) | COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS | Abstract similar documents |
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova | ||
"... Indirect comparisons of new oral anticoagulants are performed with focus on their safety. Apixaban ..." | ||
Vol 16, No 4 (2020) | Epicardial Adipose Tissue as a New Target of Therapeutic Interventions | Abstract similar documents |
M. A. Druzhilov, T. Y. Kuznetsova | ||
Vol 11, No 6 (2015) | Cardiometabolic properties of telmisartan: new perspectives for use | Abstract similar documents |
O. M. Drapkina, E. I. Fomicheva | ||
"... Modern clinical studies periodically open new prospects for the use of well-known products ..." | ||
Vol 8, No 4 (2012) | ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? | Abstract similar documents |
I. V. Zhirov | ||
Vol 14, No 4 (2018) | New Clinical Aspects of Eplerenone Use in Clinical Practice | Abstract similar documents |
S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina | ||
"... is considered in the article. Experts opinions on the reasons for this discrepancy are also presented. New data ..." | ||
Vol 16, No 6 (2020) | Healthy Diet: New Rations for Individual Use | Abstract similar documents |
O. B. Shvabskaia, N. S. Karamnova, O. V. Izmailova | ||
Vol 4, No 2 (2008) | NEWS FROM THE CONGRESS OF AMERICAN COLLEGE OF CARDIOLOGY | Abstract similar documents |
S. Y. Martsevich | ||
Vol 4, No 3 (2008) | COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION | Abstract similar documents |
D. V. Nebieridze | ||
Vol 15, No 3 (2019) | Treatment of Patients with Stable Manifestations of Atherosclerosis: New Opportunities | Abstract similar documents |
article Editorial | ||
"... of patients with coronary artery disease depending on regional particularities, the role of the new approach ..." | ||
Vol 18, No 1 (2022) | Aging Challenges. Perceived Age – a New Predictor of Longevity? | Abstract similar documents |
S. A. Shalnova, N. A. Imaeva, A. E. Imaeva, A. V. Kapustina | ||
Vol 17, No 5 (2021) | New Indicators of Myocardial Work in Healthy Individuals | Abstract PDF (Eng) similar documents |
V. E. Oleynikov, A. V. Babina, V. A. Galimskaya, A. V. Golubeva, K. N. Makarova, N. A. Donetskaya | ||
Vol 7, No 3 (2011) | THE NEWS FROM RECENT CONGRESS OF AMERICAN COLLEGE OF CARDIOLOGY (NEW ORLEANS, APRIL 2-5, 2011) | similar documents |
S. Yu. Martsevich, N. P. Kutishenko, L. Y. Drozdova | ||
Vol 20, No 4 (2024) | The evolution of evidence-based methods of acute myocardial infarction treatment: is there any reason for optimism in recent years? | Abstract similar documents |
S. Yu. Martsevich | ||
"... changes in the CG due to the lack of fundamentally new approaches to the acute MI treatment, its immediate ..." | ||
Vol 18, No 5 (2022) | Assessment and Correction of the Cardiac Complications Risk in Non-cardiac Operations – What's New? | Abstract similar documents |
A. N. Sumin | ||
"... was to provide new information about the assessment and correction of the risk of cardiac complications in non ..." | ||
Vol 19, No 1 (2023) | Arrhythmic Mitral Valve Prolapse: New Menaces of the Known Disease | Abstract similar documents |
D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko | ||
Vol 19, No 1 (2023) | Acute Coronary Syndrome during the Pandemic New Coronavirus Infection | Abstract similar documents |
O. M. Drapkina, A. Ya. Kravchenko, A. V. Budnevskiy, A. V. Kontsevaya, E. S. Ovsyannikov, E. S. Drobysheva | ||
Vol 12, No 3 (2016) | NEW METHODS OF ASSESSMENT OF SUBCLINICAL CHANGES IN THE CARDIOVASCULAR SYSTEM IN ARTERIAL HYPERTENSION | Abstract PDF (Eng) similar documents |
Zh. D. Kobalava, Yu. V. Kotovskaya, A. V. Bogomaz | ||
Vol 12, No 5 (2016) | Modulation of Cardiac Contractility – a New Method in the Treatment of Heart Failure | Abstract similar documents |
A. A. Petrukhina, S. N. Tereshchenko, I. V. Zhirov | ||
"... The review analyzes new treatment for patients with chronic heart failure (CHF) with low ejection ..." | ||
Vol 5, No 4 (2009) | ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF HEART FAILURE: WHAT IS NEW? | Abstract similar documents |
Zh. D. Kobalava | ||
"... ESC Guidelines for the diagnosis and treatment of heart failure: what is new? ..." | ||
Vol 5, No 6 (2009) | RESULTS OF THE CONTROL RANDOMIZED STUDIES IN 2009: WHAT IS NEW IN CARDIOLOGY | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina | ||
"... Results of the control randomized studies in 2009: what is new in cardiology. ..." | ||
Vol 6, No 1 (2010) | ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS | Abstract similar documents |
M. Yu. Gilyarov, V. A. Sulimov | ||
"... give special attention to new alternative drugs for prevention of thrombotic complications apart from ..." | ||
Vol 13, No 5 (2017) | DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS | Abstract similar documents |
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov | ||
"... favorable profile of drug interaction in comparison with other emnew/em oral anticoagulants (NOAC). The basis ..." | ||
Vol 14, No 1 (2018) | NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
Ju. P. Skirdenko, N. A. Nikolayev | ||
Vol 6, No 2 (2010) | EUROPEAN GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF SYNCOPE 2009. WHAT IS THE NEWS? | Abstract similar documents |
T. V. Tyurina | ||
"... European Guidelines for the diagnosis and management of syncope 2009. What is the emnews/em? ..." | ||
Vol 6, No 6 (2010) | GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) | Abstract similar documents |
Gilbert Habib, Bruno Hoen, Pilar Tornos, Franck Thuny, Bernard Prendergast, Isidre Vilacosta, Philippe Moreillon, Manuel de Jesus Antunes, Ulf Thilen, John Lekakis, Maria Lengyel, Ludwig Muller, Christoph K. Naber, Petros Nihoyannopoulos, Anton Moritz, Jose Luis Zamorano, M. O. Evseev | ||
"... Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (emnew/em version 2009). ..." | ||
Vol 6, No 5 (2010) | GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) | Abstract similar documents |
Gilbert Habib, Bruno Hoen, Pilar Tornos, Franck Thuny, Bernard Prendergast, Isidre Vilacosta, Philippe Moreillon, Manuel de Jesus Antunes, Ulf Thilen, John Lekakis, Maria Lengyel, Ludwig Muller, Christoph K. Naber, Petros Nihoyannopoulos, Anton Moritz, Jose Luis Zamorano, M. O. Evseev | ||
"... Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (emnew/em version 2009). ..." | ||
Vol 6, No 5 (2010) | THE CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY 2010 IN STOCKHOLM: NEWS FOR PRACTITIONERS | Abstract similar documents |
S. Yu. Martsevich | ||
"... emNews/em about Congress of the European Society of Cardiology 2010 in Stockholm is presented. The main ..." | ||
Vol 11, No 2 (2015) | NEWS OF EVIDENCE-BASED MEDICINE: RESULTS OF THE IMPROVE-IT TRIAL AND THEIR IMPLICATIONS FOR CLINICAL PRACTICE | Abstract similar documents |
S. Yu. Martsevich | ||
Vol 15, No 6 (2019) | New Opportunities for Improving the Prognosis of Patients with Chronic Ischemic Heart Disease | Abstract similar documents |
N. B. Perepech | ||
Vol 16, No 2 (2020) | Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development | Abstract similar documents |
O. M. Drapkina, A. N. Kaburova | ||
"... as the potentially emnew/em cardiovascular risk factor. The development of sequencing techniques, together ..." | ||
Vol 10, No 3 (2014) | NEW METABOLIC INDEX USE POTENTIALITIES IN EVALUATION OF INSULIN RESISTANCE IN CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
G. E. Roytberg, J. V. Dorosh, O. O. Sharkhun, T. I. Ushakova, E. A. Trubino | ||
"... and specificity of a emnew/em metabolic index (MI) for IR estimation in comparison with the calculated HOMA-IR index ..." | ||
Vol 9, No 2 (2013) | ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES | Abstract similar documents |
Z. M. Safiullina, S. V. Shalaev | ||
"... Studies data on emnew/em anticoagulants, direct oral thrombin inhibitor (dabigatran) and direct ..." | ||
Vol 9, No 6 (2013) | ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? | Abstract similar documents |
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein | ||
Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
A. V. Rudakova | ||
"... of venous thromboembolism (VTE) compared with low molecular weight heparin (LMWH)/warfarin and other emnew/em ..." | ||
Vol 11, No 5 (2015) | A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation | Abstract similar documents |
E. I. Emelina, G. E. Gendlin | ||
Vol 8, No 1 (2012) | NEW POSSIBILITIES IN HEART FAILURE THERAPY: POTENTIAL OF DRUGS BASED ON URSODEOXYCHOLIC ACID | Abstract similar documents |
O. M. Drapkina, O. N. Korneyeva | ||
Vol 3, No 4 (2007) | NEWS OF CONGRESS OF EUROPEAN SOCIETY OF CARDIOLOGY, VIENNA, SEPTEMBER 1-5, 2007 | Abstract similar documents |
S. Yu. Marcevich | ||
"... emNews/em of Congress of European society of cardiology, Vienna, September 1-5, 2007. ..." | ||
Vol 8, No 2 (2012) | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE | Abstract similar documents |
S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya | ||
"... to treatment, induces additional costs or may be a reason of emnew/em side effects. Additional (to standard therapy ..." | ||
Vol 14, No 2 (2018) | New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion | Abstract similar documents |
A. L. Komarov, Е. S. Novikova, E. V. Guskova, Е. B. Yarovaya, A. N. Samko, E. Р. Panchenko | ||
1 - 100 of 341 Items | 1 2 3 4 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)